Sobanski E, Poustka L. BMBF - Bundesministerium für Bildung und Forschung 01GV0605: Evaluation of Efficacy, Effectiveness and Mechanisms of a Structured Disorder Specific Psychotherapy in Attention Deficit Hyperactivity Disorder (ADHD) in Adults – The First Randomized Multicentre Study. 09/2006-12/2012.
Attention deficit hyperactivity disorder (ADHD) is a serious mental disorder with a persistent pattern of severely impaired attention and concentration, hyperactive and impulsive behaviour, emotional instability, restlessness and disorganized behaviour. The prevalence in childhood is estimated to be about 5% and in adulthood the prevalence is indicated to 2%. Comorbidity rates in adult ADHD are very high with substance abuse, antisocial behaviour, affective disorders and personality disorders. Compared to the general population adults with ADHD have lower educational status, a higher risk to be unemployed, divorced or imprisoned. Thus, about 30% of young male prison inmates suffer from ADHD (1). Therefore, ADHD has an enormous impact on the lifes of affected individuals and their familiy. In addition it cause enormous direct costs for the health system and indirect costs for the society (loss of working ours, harm caused by antisocial behaviour of adult patients with ADHD). In childhood ADHD pharmacotherapy and to a limited extent psychotherapy are well established and evaluated therapeutic options. In most cases psychotropic medication with psychostimulants is terminated in late adolescence. In contrast, there are no controlled, large multi-centre therapy studies neither for pharmacotherapy nor for psychotherapy in adult ADHD. In adult ADHD patients subjective complains often centre around psychosocial consequences of ADHD like low self es-teem or disorganised and chaotic behaviour. Consequently, patients tend to seek psychothera¬peutic instead or in addition to a psychopharmacological treatment. The German treatment guide¬lines recommend a multimodal therapy with disorder specific psychotherapy and stimulants as first choice medication.